FIELD: medicine.
SUBSTANCE: invention concerns medicine, particularly phthisiatry, and can be applied in pulmonary tuberculosis treatment. Method involves peroral administration of oxymethyluracil (OMU) in amount of 0.5 g twice per day for 10 days in addition to traditional antibacterial therapy and bacrisporin probiotic.
EFFECT: OMU application together with bactisporin allows for accelerated elimination of mycobacteria and inflammation reduction in foci, amplified immunomodulating effect of bactisporin due to oxymethyluracil effect on functional metabolic activity of blood phagocytes.
3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING SYPHILIS | 2009 |
|
RU2395283C1 |
TUBERCULOSIS TREATMENT METHOD | 2002 |
|
RU2219939C1 |
METHOD OF TREATING PATIENTS SUFFERING PULMONARY TUBERCULOSIS | 2012 |
|
RU2491077C1 |
METHOD OF PULMONARY TUBERCULOSIS TREATMENT | 2006 |
|
RU2329803C1 |
METHOD FOR TREATING PULMONARY TUBERCULOSIS | 2006 |
|
RU2302251C1 |
METHOD OF TREATING PATIENTS WITH PULMONARY TUBERCULOSIS | 2008 |
|
RU2380113C1 |
METHOD OF TREATMENT OF PULMONARY TUBERCULOSIS | 2007 |
|
RU2323739C1 |
METHOD OF TREATING PATIENTS WITH DESTRUCTIVE FORMS OF PULMONARY TUBERCULOSIS | 2013 |
|
RU2521197C1 |
METHOD OF TREATING PULMONARY TUBERCULOSIS | 2011 |
|
RU2452495C1 |
METHOD FOR TREATING DIFFERENT FORMS OF PULMONARY TUBERCULOSIS, RESISTANT TO ANTITUBERCULAR CHEMOTHERAPY, AMONG THEM | 2001 |
|
RU2197984C1 |
Authors
Dates
2009-06-10—Published
2008-01-28—Filed